Fennec Pharmaceuticals Inc. (TSX:FRX)
11.36
-1.15 (-9.19%)
Aug 14, 2025, 11:48 AM EDT
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of CAD 346.40 million as of August 14, 2025. Its market cap has increased by 45.91% in one year.
Market Cap
346.40M
Enterprise Value
341.83M
Revenue
44.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.36
Market Cap Chart
Since November 12, 2004, Fennec Pharmaceuticals's market cap has increased from 89.84M to 346.40M, an increase of 285.60%. That is a compound annual growth rate of 6.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 346.40M | 38.67% |
Dec 31, 2024 | 249.80M | -36.88% |
Dec 29, 2023 | 395.77M | 15.99% |
Dec 30, 2022 | 341.20M | 135.62% |
Dec 31, 2021 | 144.81M | -40.90% |
Dec 31, 2020 | 245.01M | 46.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 3.23B |
Green Thumb Industries | 2.62B |
Trulieve Cannabis | 2.38B |
Sienna Senior Living | 1.75B |
dentalcorp Holdings | 1.61B |
Cronos Group | 1.35B |
WELL Health Technologies | 1.22B |
Extendicare | 1.13B |